scispace - formally typeset
R

Robert J. Goulet

Researcher at Indiana University

Publications -  35
Citations -  3913

Robert J. Goulet is an academic researcher from Indiana University. The author has contributed to research in topics: Metastasis & Breast cancer. The author has an hindex of 20, co-authored 35 publications receiving 3745 citations.

Papers
More filters
Journal ArticleDOI

CD44 + /CD24 - breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis

TL;DR: Breast cancer cells with CD44+/CD24- subpopulation express higher levels of proinvasive genes and have highly invasive properties, however, this phenotype is not sufficient to predict capacity for pulmonary metastasis.
Journal ArticleDOI

Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth.

TL;DR: Since ER inhibits the constitutive as well as inducible activation function of NF-kappaB in a dose-dependent manner, it is proposed that breast cancers that lack functional ER overexpress NF- kappaB-regulated genes.
Journal ArticleDOI

Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.

TL;DR: It is concluded that carboplatin and etoposide can be administered in combination at high dosages and this regimen may have curative potential for patients with germ cell tumors resistant to conventional-dose cisplatin-based therapies.
Journal ArticleDOI

Paclitaxel sensitivity of breast cancer cells with constitutively active NF-κB is enhanced by IκBα super-repressor and parthenolide

TL;DR: It is shown that constitutive activation of NF-κB leads to overexpression of the anti-apoptotic genes c-inhibitor of apoptosis 2 (c-IAP2) and manganese superoxide dismutase (Mn-SOD) in breast cancer cells, and Parthenolide, an active ingredient of herbal remedies, mimicked the effects of IκBα by inhibiting NF-σκB DNA binding activity and Mn-S
Journal ArticleDOI

Effect of Matrix Metalloproteinase Inhibitor Batimastat on Breast Cancer Regrowth and Metastasis in Athymic Mice

TL;DR: Whether batimastat, given as adjuvant therapy after primary tumor resection, could inhibit local-regional tumor regrowth and the formation of lung metastases in a human breast cancer xenograft model is asked and its effects on breast cancer cell viability and on the accumulation of specific messenger RNAs (mRNAs) are explored.